June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Influence of tobacco smoking on developing age-related ectropion and entropion
Author Affiliations & Notes
  • Zane Z. Yu
    Division of Ophthalmology, Brown University Warren Alpert Medical School, Providence, Rhode Island, United States
  • Philip Rizzuto
    Division of Ophthalmology, Brown University Warren Alpert Medical School, Providence, Rhode Island, United States
  • Footnotes
    Commercial Relationships   Zane Yu None; Philip Rizzuto None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2130 – A0158. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zane Z. Yu, Philip Rizzuto; Influence of tobacco smoking on developing age-related ectropion and entropion. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2130 – A0158.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Studies have shown that tobacco smoking significantly impacts general health and well-being. Tobacco smoking also has a multitude of negative consequences on ocular health, increasing the risk of age-related macular degeneration, cataracts, and glaucoma. The purpose of this study was to assess the impact of tobacco smoking on age-related ectropion and entropion.

Methods : Data on ectropion and entropion cases from a clinical practice from the years 2017 to 2019 were analyzed. Ages of non-smoking ectropion and entropion patients were compared with ages of ectropion and entropion smokers using normal distributions.

Results : The null hypothesis was that the average age of a smoker presenting with ectropion or entropion would not be significantly different from that of a non-smoking patient. The alternative hypothesis was the average age of a smoker presenting with ectropion or entropion would be younger. There were 101 non-smokers and 50 smokers in the dataset. The average age of a non-smoking patient presenting with ectropion or entropion was 77.78 with a standard deviation of 10.31. From a sample size of 50, the average age of a smoker presenting with ectropion or entropion was 74.44 with a standard deviation of 11.84. Z-test analysis reveals a Z-statistic of 1.70, giving a p-value of 0.045 for a one-tailed hypothesis. Using a standard confidence interval of 95%, this allows us to reject the null hypothesis.

Conclusions : Given the significantly lower average age of presentation with age-related ectropion or entropion in smokers compared to non-smokers, tobacco smoking is evidently associated with earlier age of onset in cases of age-related ectropion or entropion. The data only includes patients from around the Rhode Island area – potentially including Massachusetts and Connecticut – and cannot be reliably extrapolated to broader populations; additionally, this study did not address potential increases in risk of age-related ectropion or entropion in smokers. More research will need to be done to elucidate the association between tobacco smoking and age-related ectropion and entropion.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×